Laddar...
Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
The use of carrier cells infected with oncolytic viruses in cancer gene therapy is an attractive method because it can overcome viral immunogenicity and induce tumor immunity and significant antitumor activity. To enable human clinical trials of this treatment, acute and chronic toxicity tests must...
Sparad:
| I publikationen: | Mol Ther Methods Clin Dev |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362384/ https://ncbi.nlm.nih.gov/pubmed/26015963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2014.19 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|